Central Nervous System Stimulants
-
Subject Areas on Research
-
"Model" behavior.
-
"Nothing Is Free": A Qualitative Study of Sex Trading Among Methamphetamine Users in Cape Town, South Africa.
-
3-year follow-up of the NIMH MTA study.
-
Letter to the Editor:
Differences in Rate of Stimulant Medication Use for Attention-Deficit/Hyperactivity Disorder by Western and Non-Western Origins.
-
A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR®) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder.
-
A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder.
-
A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA).
-
A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
-
A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
-
A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.
-
A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.
-
A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD.
-
A psychometric evaluation of the Concise Health Risk Tracking Self-Report (CHRT-SR)- a measure of suicidality-in patients with stimulant use disorder.
-
A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
-
A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.
-
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
-
A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia.
-
ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.
-
ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
-
Abnormal fronto-limbic engagement in incarcerated stimulant users during moral processing.
-
Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).
-
Activity patterns in mesolimbic regions in rats during operant tasks for reward.
-
Acute Heart Failure in a 39-Year-Old Man.
-
Adderall, the atypicals, and weight gain.
-
Adjustment to college in students with ADHD.
-
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
-
Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.
-
Alcohol use and consequences in matriculating US college students by prescription stimulant/opioid nonmedical misuse status.
-
Amphetamine trials and tribulations.
-
Amphetamines and related drugs in motor recovery after stroke.
-
An evidence-based medicine approach to combined treatment for ADHD in children and adolescents.
-
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.
-
An observational study of pharmacological treatment in primary care of children with ADHD in the United kingdom.
-
Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA).
-
Appetite and weight in children treated for ADHD.
-
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
-
Assessing medication effects in the MTA study using neuropsychological outcomes.
-
Assessing methylphenidate preference in ADHD patients using a choice procedure.
-
Assessment of brain activity during memory encoding in a narcolepsy patient on and off modafinil using normative fMRI data.
-
Attention-deficit/hyperactivity disorder among chronic methamphetamine users: frequency, persistence, and adverse effects on everyday functioning.
-
Attention-deficit/hyperactivity disorder and the explore/exploit trade-off.
-
Attenuation of pharmacologically-induced attentional impairment by methylphenidate in rats.
-
Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.
-
Caffeine affects cardiovascular and neuroendocrine activation at work and home.
-
Caffeine deprivation affects vigilance performance and mood.
-
Caffeine withdrawal symptoms following brief caffeine deprivation.
-
Can methylphenidate objectively provide relief in patients with uncontrolled blepharospasm? A pilot study using surface electromyography.
-
Child and parent predictors of perceptions of parent--child relationship quality.
-
Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
-
Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.
-
Cognitive Testing to Identify Children With ADHD Who Do and Do Not Respond to Methylphenidate.
-
Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia.
-
Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.
-
Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
-
Comparing pharmacological treatments for cocaine dependence: Incorporation of methods for enhancing generalizability in meta-analytic studies.
-
Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
-
Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate.
-
Comprehensive versus matched psychosocial treatment in the MTA study: conceptual and empirical issues.
-
Conclusions inconsistent with results with amphetamines and divalproex.
-
Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD.
-
Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults.
-
Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers.
-
Desensitization of G protein-coupled receptors and neuronal functions.
-
Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.
-
Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice.
-
Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD).
-
Dissociable roles for the basolateral amygdala and orbitofrontal cortex in decision-making under risk of punishment.
-
Dopaminergic abnormalities in Hdac6-deficient mice.
-
Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice.
-
Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: an exploratory study.
-
Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
-
Drug use and validity of substance use self-reports in veterans seeking help for posttraumatic stress disorder.
-
EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: relations to depressive traits, nicotine exposure, and dependence.
-
Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats.
-
Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial.
-
Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
-
Effects of brief caffeinated-beverage deprivation on mood, symptoms, and psychomotor performance.
-
Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder.
-
Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD.
-
Effects of lisdexamfetamine dimesylate treatment for ADHD on growth.
-
Effects of methylphenidate on sensitivity to reinforcement in children diagnosed with attention deficit hyperactivity disorder: an application of the matching law.
-
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up.
-
Effects of sub-chronic methylphenidate on risk-taking and sociability in zebrafish (Danio rerio).
-
Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.
-
Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
-
Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension.
-
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.
-
Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.
-
Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution.
-
Emerging drugs for attention-deficit/hyperactivity disorder.
-
Emerging pharmacotherapy for cancer patients with cognitive dysfunction.
-
Enantioselective determination of methylphenidate and ritalinic acid in whole blood from forensic cases using automated solid-phase extraction and liquid chromatography-tandem mass spectrometry.
-
Enduring behavioral effects of early exposure to methylphenidate in rats.
-
Epigenetics and psychostimulant addiction.
-
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details.
-
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary.
-
Failure to suppress low-frequency neuronal oscillatory activity underlies the reduced effectiveness of random patterns of deep brain stimulation.
-
Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment.
-
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers.
-
Follow-Up of Young Adults With ADHD in the MTA: Design and Methods for Qualitative Interviews.
-
Frequency-dependent, transient effects of subthalamic nucleus deep brain stimulation on methamphetamine-induced circling and neuronal activity in the hemiparkinsonian rat.
-
Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models.
-
HIV infection among female drug users in Northern Thailand.
-
HIV testing behaviors and attitudes among community recruited methamphetamine users in a South African township.
-
Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial.
-
Individual differences in psychostimulant responses of female rats are associated with ovarian hormones and dopamine neuroanatomy.
-
Injection drug use among stimulant users in a national sample.
-
Intranasal Use of Prescription Stimulants Among Adults Aged 18 to 30: Results From A Crowdsourcing Platform.
-
JHSB Policy Brief. Does Medical Treatment of Children's Behavioral Problems Lower Foster Care Rates?
-
Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [18
F]fallypride PET.
-
Lisdexamfetamine Dimesylate (Vyvanse) for the Treatment of Neurogenic Anejaculation.
-
Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder.
-
Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD.
-
Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD.
-
Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors.
-
Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.
-
Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder.
-
Magnitude and ethanol sensitivity of tonic GABAA receptor-mediated inhibition in dentate gyrus changes from adolescence to adulthood.
-
MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants.
-
MeCP2 phosphorylation limits psychostimulant-induced behavioral and neuronal plasticity.
-
Mecamylamine increases cigarette smoking in psychiatric patients.
-
Mediators of interpersonal violence and drug addiction severity among methamphetamine users in Cape Town, South Africa.
-
Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment.
-
Medication treatment strategies in the MTA Study: relevance to clinicians and researchers.
-
Menthol disrupts nicotine's psychostimulant properties in an age and sex-dependent manner in C57BL/6J mice.
-
Methamphetamine use is associated with childhood sexual abuse and HIV sexual risk behaviors among patrons of alcohol-serving venues in Cape Town, South Africa.
-
Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD.
-
Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).
-
Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
-
Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial.
-
Methylphenidate increases willingness to perform effort in adults with ADHD.
-
Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.
-
Methylphenidate-induced autoimmune hepatitis.
-
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants.
-
Misuse of methamphetamine and prescription stimulants among youths and young adults in the community.
-
Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial.
-
Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment.
-
Modulation of decompression sickness risk in pigs with caffeine during H(2) biochemical decompression.
-
More Evidence That Caffeine Consumption Appears to Be Safe in Patients With Heart Failure.
-
Neonatal Escherichia coli infection alters glial, cytokine, and neuronal gene expression in response to acute amphetamine in adolescent rats.
-
Neural cell adhesion molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alterations in behavior.
-
Nicotine-antipsychotic drug interactions and attentional performance in female rats.
-
On chronic fatigue syndrome.
-
Open-Label Dose Optimization of Methylphenidate Extended-Release Orally Disintegrating Tablet in a Laboratory Classroom Study of Children with Attention-Deficit/Hyperactivity Disorder.
-
PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.
-
Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
-
Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study.
-
Pediatric narcolepsy.
-
Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder.
-
Performance-enhancing drugs.
-
Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafish.
-
Pharmacogenetics of methylphenidate response in preschoolers with ADHD.
-
Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.
-
Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate.
-
Pharmacotherapy for Preschool Children with Attention Deficit Hyperactivity Disorder (ADHD): Current Status and Future Directions.
-
Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up.
-
Poststroke treatment: lost in translation.
-
Postsynaptic Mechanisms Render Syn I/II/III Mice Highly Responsive to Psychostimulants.
-
Predictors of nonmedical ADHD medication use by college students.
-
Present and future pharmacotherapeutic options for adult attention deficit/hyperactivity disorder.
-
Psychopharmacological interactions between nicotine and ethanol.
-
Psychopharmacological treatment for very young children: contexts and guidelines.
-
Psychosocial treatments for preschool-aged children with Attention-Deficit Hyperactivity Disorder.
-
Psychostimulant dependence in a community sample.
-
Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder.
-
Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
-
Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS).
-
Recent advances in poststroke depression.
-
Recommendations for high-priority research on cancer-related fatigue in children and adults.
-
Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD).
-
Relationship of prolactin response to meta-chlorophenylpiperazine with severity of drug use in cocaine dependence.
-
Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder.
-
Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.
-
Safety and tolerability of methylphenidate in preschool children with ADHD.
-
Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses.
-
Sex differences in novelty- and psychostimulant-induced behaviors of C57BL/6 mice.
-
Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.
-
Stimulant prescription cautions: addressing misuse, diversion and malingering.
-
Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial.
-
Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design.
-
Stimulant treatment for children: a community perspective.
-
Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.
-
Subjective effects and changes in steroid hormone concentrations in humans following acute consumption of alcohol.
-
The Effect of Medical Treatment of Attention Deficit Hyperactivity Disorder (ADHD) on Foster Care Caseloads: Evidence from Danish Registry Data.
-
The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.
-
The Importance of Scrutinizing Emergent ADHD Symptoms in Adults: Response to Chamberlain and Müller.
-
The effects of environmental noise and infant position on cerebral oxygenation.
-
The misuse and diversion of prescribed ADHD medications by college students.
-
The role of substance use coping in the relation between childhood sexual abuse and depression among methamphetamine users in South Africa.
-
The what, where, and when of catechol-O-methyltransferase.
-
Tobacco smoking and other suspected antecedents of nonmedical psychostimulant use in the United States, 1995.
-
Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder.
-
Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.
-
Which treatment for whom for ADHD? Moderators of treatment response in the MTA.
-
Wide variation in caffeine discontinuation timing in premature infants.
-
Keywords of People